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There  was  a  time  when  tobacco  was  thought  to  have  medic-
inal  qualities  and  another  time  when  tobacco  consumption
was  common,  fashionable,  and  ubiquitous,  and  considered
socially  acceptable.  However,  statistical  evidence  suggest-
ing  a  relationship  between  smoking  and  lung  cancer  began  to
emerge  in  the  late  1920s,  although  scientific  evidence  of  a
causal  relationship  was  not  available  until  the  mid-twentieth
century.  Since  then,  epidemiologists  have  collected  evi-
dence  in  large  prospective  and  case-control  studies  to
support  a  causal  relationship  between  smoking  and  various
diseases,  chiefly  cancer  and  cardiovascular  and  chronic  res-
piratory  diseases.  As  evidence  on  the  negative  effects  of
tobacco  use  accumulated,  numerous  organizations  produced
technical  reports  with  programs  and  strategies  for  tobacco
control  that  changed  the  course  of  public  health.  However,
despite  some  success  in  implementing  evidence-based  poli-
cies  and  programs  that  have  decreased  smoking  rates  in
recent  decades,  more  effective  strategies  are  needed  to  end
the  tobacco  epidemic.
The  history  of  the  science  linking  tobacco  to  diseases
goes  back  nearly  a  century,  but  some  articles  and  reports
are  true  milestones  that  should  be  highlighted.  Landmark
articles  were  published  by  Doll  and  Hill  and  by  Wynder  and
Graham  in  1950  on  case-control  studies  linking  smoking  and
lung  cancer  in  a  causal  relationship.1,2 The  scientific  and
medical  communities  both  cast  doubt  on  the  findings,  but  by
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tudy  with  fifty  years  of  follow-up,  with  Austin  Bradford  Hill
tarting  in  1951.3,4 In  1962,  the  UK’s  Royal  College  of
hysicians  issued  a  report  which  clearly  indicated  cigarette
moking  as  a  cause  of  lung  cancer  and  bronchitis  and
rgued  that  it  probably  contributed  to  cardiovascular  dis-
ase  as  well.5 The  relationship  between  smoking  and  the
isk  of  coronary  heart  disease  (CHD)  was  discussed  in  the  US
urgeon  General’s  report  in  1964,6 and  the  1979  report  con-
luded  that  smoking  is  causally  related  to  CHD  for  both  men
nd  women.  Subsequent  Surgeon  General’s  reports  (1983,
986,  1989,  2004  and  2006)  extended  this  association  to
ther  atherosclerotic  diseases,  including  peripheral  vascular
isease,  abdominal  aortic  aneurysm  and  stroke.  The  exis-
ence  of  this  causal  relationship  is  consistent  with  the  results
f  other  prospective7 and  case-control  studies.8,9 The  2001
eport  covers  exposure  to  secondhand  smoke  and  cardio-
ascular  disease  and  found  that  the  evidence  did  indicate  a
ausal  relationship.  The  2006  report  found  that  the  evidence
s  sufficient  to  infer  a  causal  relationship  between  expo-
ure  to  secondhand  smoke  and  CHD,  particularly  a  reduction
n  coronary  events  among  people  younger  than  65  years
f  age  following  the  implementation  of  a  smokefree  law
r  policy,  while  the  evidence  is  suggestive  but  not  suffi-
ient  for  other  heart  disease  outcomes  or  cerebrovascular
vents.10,11
The  response  of  the  World  Health  Organization  (WHO)
as  been  to  lead  a  remarkable  campaign  for  tobacco  con-
rol  over  the  past  50  years.  After  the  reports  presented
o  the  23rd  and  24th  World  Health  Assemblies  (1970  and
971),  the  WHO  expert  committee  made  recommendations
n  ‘‘Smoking  and  its  effects  on  health’’,  in  1974  (techni-
























































































































al  report  series  no.  568),  and  ‘‘Controlling  the  smoking
pidemic’’,  in  1978  (technical  report  series  no.  636).  In
he  latter  report,  the  Committee  argues  that  the  United
ations  system  and  the  World  Bank  have  as  a  whole  not  yet
ccepted  the  importance  of  their  involvement  in  a  world
moking  control  program  and  recommends  that  appropri-
te  action  should  be  taken  as  soon  as  possible.  As  a  public
ealth  problem,  governments  should  accept  responsibility
or  carrying  out  smoking  control  actions  by  their  agencies
nd  stimulate  non-governmental  organizations  to  also  take
ction.  Since  then,  measures  have  been  presented  to  control
he  tobacco  epidemic  and  the  WHO  has  produced  reports  on
he  global  tobacco  epidemic  outlining  developments  in  the
eld.  In  force  since  2005,  the  WHO  Framework  Convention
n  Tobacco  Control  (FCTC),  the  first  treaty  negotiated  under
he  auspices  of  the  WHO,  is  one  of  the  most  widely  embraced
reaties  in  United  Nations  history.12 It  currently  has  181  Par-
ies,  covering  more  than  90%  of  the  world’s  population,
nd  represents  a  paradigm  shift  in  developing  a  regula-
ory  strategy  to  address  addictive  substances,  asserting  the
mportance  of  demand  reduction  strategies  as  well  as  supply
ssues.  It  is  a  milestone  in  the  promotion  of  public  health,
n  evidence-based  treaty  that  provides  legal  dimensions  for
nternational  health  cooperation  and  sets  high  standards
or  compliance.13
In  2007,  the  WHO  introduced  a  practical  way  to  promote
overnment  action  on  six  evidence-based  components,  the
ssential  elements  of  tobacco  control  strategy  in  line  with
he  FCTC:  MPOWER.14 The  WHO  has  been  monitoring  the
mpact  of  MPOWER’s  policies  since  2007  and  every  two  years
ince  2008  has  published  a  WHO  report  on  the  global  tobacco
pidemic.  The  focus  of  the  latest  report  (2019,  the  seventh)
s  on  the  progress  that  countries  have  made  to  offer  help  to
uit  smoking.  In  the  report,  Dr.  Tedros  Adhanom,  Director-
eneral  of  the  WHO,  says:  ‘‘Tobacco  control  is  a perfect
xample  of  what  can  be  achieved  in  global  health  through
lobal  commitments....  Providing  access  to,  and  encour-
ging  the  use  of,  effective  cessation  interventions  greatly
ncreases  the  likelihood  of  successfully  quitting  tobacco....
C]ost-effective  tobacco  cessation  interventions  must  be
 priority  for  countries.  At  the  same  time,  innovation  is
o  be  encouraged  and  mobile  technologies  should  be  fully
arnessed  to  improve  access  to  large  and  hard-to-reach  pop-
lations....  The  MPOWER  measures  can  assist  governments
y  providing  key  tools  to  combat  the  global  tobacco  epi-
emic.’’15
However,  tobacco  use  is  still  the  second  leading  cause
f  death  in  the  world  and  the  leading  cause  of  premature
eath,  due  to  the  many  diseases  that  are  attributed  com-
letely  or  partially  to  smoking.16,17 Since  the  adoption  of
he  WHO  FCTC  15  years  ago,  there  have  been  innovations
n  tobacco  control  programs  and  policies  worldwide,  but
urrent  levels  of  implementation  of  evidence-based  policies
nd  programs  are  not  as  effective  as  they  need  to  be.  For
xample,  the  proportion  of  daily  smokers  has  decreased  in
ost  of  the  36  countries  of  the  Organisation  for  Economic
o-operation  and  Development  over  the  last  decade,  from
n  average  of  23%  in  2007  to  18%  in  2017.  Between  the  top
erformer  (7.6%)  and  bottom  performer  (27.3%)  are  Portugal
16.8%)  and  Spain  (22.1%).  People  with  a  lower  educational
evel  are  more  likely  to  smoke  in  all  countries.  However,






ighest  and  lowest  education  level)  is  relatively  small  in
ome  countries  (Portugal,  Bulgaria,  Lithuania,  Turkey,  Spain,
nd  France).18
The  study  by  Carrión-Valero  et  al.  in  this  issue  of  the
ournal  assessed  the  impact  of  laws  restricting  tobacco
dvertising,  promotion  and  sponsorship  and  protecting
eople  from  involuntary  exposure  to  tobacco  smoke  in  the
ommunity  of  Valencia  (Spain),  with  significant  effects  on
ospitalization  rates  for  acute  myocardial  infarction  (AMI).19
he  study  design  involves  time  series  analyses  with  tech-
iques  for  modeling  the  trends  of  the  series.  The  main
rocedure  in  the  construction  of  the  prediction  model  was
ased  on  the  observed  behavior  of  the  time  series  and  was
ot  based  on  theories  and  did  not  include  many  variables.
he  authors  report  that  the  adjusted  hospital  admission
ate  decreased  from  141.1/100  000  in  2005  to  102.9  in
013,  a  reduction  of  27%.  There  is  biological  plausibility
or  inferring  that  this  significant  reduction  in  hospitaliza-
ion  for  AMI  is  causally  associated  with  the  implementation
f  a  comprehensive  smoking  ban,  justifying  the  implemen-
ation  of  similar  laws.  Nevertheless,  given  some  limitations
f  the  methodology,  the  effect  size  should  be  interpreted
ith  some  caution.  Firstly,  the  lack  of  assessment  of  either
assive  smoking  (by  measuring  cotinine  levels)  or  the  preva-
ence  of  smoking  over  the  time  period  under  analysis  limits
he  ability  to  assess  the  impact  of  the  comprehensive  smok-
ng  ban.  The  inherent  inability  to  discriminate  inpatient
ases  of  AMI  and  to  analyze  other  variables  related  to  the
ncidence  of  AMI  (including  time-varying  confounders)  are
imitations  to  be  aware  of.  Indeed,  there  are  multiple  fac-
ors  influencing  the  occurrence  of  AMI,  in  terms  of  both
isk  and  medical  care  (including  prevention),  that  are  not
nalyzed.  Secondly,  the  impact  specifically  attributable  to
he  smoke-free  laws  (Law  28/2005  and  Law  42/2010),  which
ere  popular  with  the  public  and  thus  easy  to  pass,  cannot
e  assessed  without  taking  into  account  compliance  with  the
ix  MPOWER  components.  Spain  has  in  fact  achieved  a  high
evel  of  compliance,  with  a  complete  policy  for  four  mea-
ures  (monitoring,  health  warnings,  advertising  bans,  and
axation)  and  a  moderate  policy  for  one  measure,  cessation
rograms.20 However,  there  are  other  investigations  with
ess  positive  results.  In  time  series  analysis,  one  well-known
ethodological  challenge  is  how  to  adjust  the  analysis  for
ecular  trends,  in  this  case  of  declining  morbidity  and  mor-
ality  from  cardiovascular  disease.  The  heterogeneity  of  this
ype  of  study  is  a  recognized  difficulty  in  the  literature,
ainly  related  to  the  degree  to  which  the  models  need  to
e  adjusted.11
For  the  future  and  from  a  global  perspective,  new  devel-
pments  have  to  take  place.  The  following  facts  are  known:
obacco  kills  8  million  people  a  year  around  the  world  from
irect  use  and  exposure  to  secondhand  smoke;  surveillance
s  key;  tobacco  users  need  help  to  quit;  health  warnings
ork;  bans  on  tobacco  advertising  lower  consumption;  taxes
re  effective  in  reducing  tobacco  use;  and  illicit  trade  in
obacco  products  must  be  stopped.21 The  WHO  FCTC  has
een  ratified  by  181  Member  States  and  tools  (MPOWER)
o  help  countries  implement  its  measures  have  been  intro-
uced.  However,  only  23  countries  offer  smoking  cessation
ervices  provided  at  best-practice  levels,15 meaning  that
hey  include  national  toll-free  quit  lines,  ‘‘mCessation’’














Tobacco  use:  More  needs  to  be  done  to  control  active  and  p
phones,  counseling  by  primary  health  care  providers,  and
cost-effective  nicotine  replacement  therapy.15,21 Smoking
cessation  support  is  a  sine  qua  non  to  achieve  the  WHO
Sustainable  Development  Goal  (SDG)  target  (SDG3.4)  on  non-
communicable  diseases  (NCDs):  by  2030,  ‘‘to  reduce  by  one
third  premature  mortality  from  NCDs  through  prevention
and  treatment’’.22
There  have  unquestionably  been  successes  in  the  fight
against  the  smoking  epidemic,  but  prevention  of  tobacco
use  is  still  far  from  being  achieved,  and  if  we  want  the  next
generation  to  be  tobacco-free,  there  is  still  much  work  to
be  done.
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